Author + information
Jerez-Valro M, Urena M, Webb JG, et al.
Clinical Impact of Aortic Regurgitation After Transcatheter Aortic Valve Replacement: Insights Into the Degree and Acuteness of Presentation.
J Am Coll Cardiol Intv 2014;7:1022–32.
Discrepancies were discovered for some of the p values in the Results paragraph of the abstract. The correct version of the Results paragraph appears here:
Results Residual AR was classified as mild in 761 patients (43.9%) and moderate to severe in 247 patients (14.2%). The presence of moderate to severe AR was an independent predictor of mortality at a mean follow-up of 21 ± 17 months compared with none to trace (adjusted hazard ratio [HR]: 1.81, 95% confidence interval [CI]: 1.32 to 2.48; p < 0.001) and mild AR (adjusted HR: 1.68, 95% CI: 1.27 to 2.24; p < 0.001) groups. There was no increased risk in patients with mild AR compared with those with none to trace AR (p = 0.393). In patients with moderate to severe AR, acute AR was observed in 161 patients (65%) and chronic AR in 86 patients (35%). Acute moderate to severe AR was independently associated with increased risk of mortality compared with none/trace/mild AR (adjusted HR: 2.37, 95% CI: 1.53 to 3.66; p < 0.001) and chronic moderate to severe AR (adjusted HR: 2.24, 95% CI: 1.17 to 4.30; p = 0.015). No differences in survival rate were observed between patients with chronic moderate to severe and none/trace/mild AR (p > 0.50).
A discrepancy was also discovered in the number of patients in the study population. A total of 1,783 consecutive patients undergoing TAVR with balloon-expandable valves (1,005 patients) and self-expanding valves (778 patients) at 8 centers were evaluated.
The authors regret the error.
- American College of Cardiology Foundation